Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells 1,333 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Christopher J. Joyce sold 1,333 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $9.00, for a total transaction of $11,997.00. Following the transaction, the insider now directly owns 405,579 shares in the company, valued at $3,650,211. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Alignment Healthcare Trading Up 3.9 %

Shares of ALHC stock traded up $0.34 during trading hours on Tuesday, hitting $9.17. 677,296 shares of the company were exchanged, compared to its average volume of 944,135. The firm has a market cap of $1.75 billion, a PE ratio of -11.10 and a beta of 1.43. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $10.16. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.23. The firm has a fifty day moving average of $8.34 and a 200 day moving average of $6.76.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Thursday, August 1st. The company reported ($0.13) earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.01. The business had revenue of $681.29 million for the quarter, compared to analyst estimates of $637.66 million. Alignment Healthcare had a negative net margin of 6.85% and a negative return on equity of 95.55%. The company’s revenue was up 47.3% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.15) EPS. Analysts expect that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on ALHC shares. Stephens upped their price target on shares of Alignment Healthcare from $6.00 to $7.00 and gave the stock an “equal weight” rating in a research note on Friday, May 3rd. Robert W. Baird started coverage on shares of Alignment Healthcare in a research note on Thursday, May 30th. They set an “outperform” rating and a $10.00 price target on the stock. TD Cowen upped their price target on shares of Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a research note on Tuesday. Stifel Nicolaus boosted their price objective on shares of Alignment Healthcare from $9.00 to $12.00 and gave the stock a “buy” rating in a research report on Friday, July 26th. Finally, Barclays boosted their price objective on shares of Alignment Healthcare from $4.50 to $7.00 and gave the stock an “underweight” rating in a research report on Monday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Alignment Healthcare currently has an average rating of “Moderate Buy” and an average target price of $9.95.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of ALHC. Jacobs Levy Equity Management Inc. acquired a new stake in Alignment Healthcare during the 1st quarter worth approximately $918,000. Jump Financial LLC acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $575,000. Vanguard Group Inc. increased its position in Alignment Healthcare by 3.7% during the 3rd quarter. Vanguard Group Inc. now owns 9,121,432 shares of the company’s stock worth $63,303,000 after purchasing an additional 322,661 shares in the last quarter. Barlow Wealth Partners Inc. acquired a new stake in Alignment Healthcare during the 4th quarter worth approximately $100,000. Finally, Assenagon Asset Management S.A. increased its position in Alignment Healthcare by 283.9% during the 1st quarter. Assenagon Asset Management S.A. now owns 315,629 shares of the company’s stock worth $1,566,000 after purchasing an additional 233,417 shares in the last quarter. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.